{"log_id": 7273721463041320267, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0.001945, "average": 0.9817, "min": 0.856897}, "location": {"width": 568, "top": 147, "height": 62, "left": 266}, "words": "连续3天。患者可预先使用常规止吐药"}, {"probability": {"variance": 0.028477, "average": 0.881574, "min": 0.591286}, "location": {"width": 134, "top": 199, "height": 38, "left": 331}, "words": "给药周期"}, {"probability": {"variance": 0.002866, "average": 0.975425, "min": 0.754234}, "location": {"width": 1064, "top": 237, "height": 84, "left": 337}, "words": "每6周重复一个周期。推荐至少重复4个周期。然而,获得完全缓解或部"}, {"probability": {"variance": 0.000195, "average": 0.99439, "min": 0.922797}, "location": {"width": 1051, "top": 279, "height": 82, "left": 261}, "words": "分缓解的患者可以治疗4个周期以上。如果患者能继续获益可以持续用药"}, {"probability": {"variance": 0.003666, "average": 0.979302, "min": 0.707485}, "location": {"width": 764, "top": 364, "height": 69, "left": 319}, "words": "依据血液学实验室检查值进行的剂量调整或延迟给药"}, {"probability": {"variance": 0.011261, "average": 0.959621, "min": 0.540443}, "location": {"width": 1064, "top": 404, "height": 87, "left": 331}, "words": "如果经过前一个周期的地西他滨治疗,血液学恢复〈中性粒细胞绝对计数"}, {"probability": {"variance": 0.016252, "average": 0.944435, "min": 0.404963}, "location": {"width": 1136, "top": 449, "height": 84, "left": 257}, "words": "ANC]≥1,00L,血小板≥50/L)需要超过6周,则下一周期的治疗应延"}, {"probability": {"variance": 0.001089, "average": 0.987894, "min": 0.852045}, "location": {"width": 630, "top": 492, "height": 69, "left": 254}, "words": "迟,且剂量应按以下原则进行暂时性的调整"}, {"probability": {"variance": 0.003618, "average": 0.973818, "min": 0.716426}, "location": {"width": 1073, "top": 539, "height": 84, "left": 319}, "words": "恢复时问超过6周,但少于8周给药应延迟2周,且重新开始治疗剂量减"}, {"probability": {"variance": 0.020246, "average": 0.9042, "min": 0.430949}, "location": {"width": 894, "top": 583, "height": 71, "left": 248}, "words": "少到11mgm,每8小时一次,(33mghm2天:9mgn2周期);"}, {"probability": {"variance": 0.010984, "average": 0.961977, "min": 0.507994}, "location": {"width": 1066, "top": 628, "height": 78, "left": 319}, "words": "恢复时间超过8周,但少于10周-患者应进行疾病进展的评估(通过骨髓穿"}, {"probability": {"variance": 0.012089, "average": 0.951265, "min": 0.563112}, "location": {"width": 1136, "top": 666, "height": 87, "left": 248}, "words": "刺评估),如未出现进展,给药应延迟2周以上,重新开始时剂量应减少到"}, {"probability": {"variance": 0.020884, "average": 0.909645, "min": 0.450926}, "location": {"width": 1116, "top": 713, "height": 87, "left": 250}, "words": "1mgm2,每8小时一次33mg/m3天:99mg/m2周期),然后在接下来的周期中"}, {"probability": {"variance": 9.4e-05, "average": 0.992742, "min": 0.964044}, "location": {"width": 431, "top": 758, "height": 60, "left": 248}, "words": "根据临床情况维持或增加剂量"}, {"probability": {"variance": 0.003643, "average": 0.974264, "min": 0.730747}, "location": {"width": 662, "top": 845, "height": 62, "left": 308}, "words": "依据非血液学毒性进行的剂量调整或延迟给药"}, {"probability": {"variance": 0.004286, "average": 0.974672, "min": 0.64189}, "location": {"width": 1069, "top": 887, "height": 80, "left": 310}, "words": "在第一个地西他滨治疗周期后,如果出现以下非血液学毒性,暂停地西他滨"}, {"probability": {"variance": 0.015138, "average": 0.929348, "min": 0.573249}, "location": {"width": 1221, "top": 928, "height": 89, "left": 239}, "words": "用药直至毒性消失:1)血清肌酐≥2mgdL;2)丙氨酸氨基转移酶(ALT)、总"}, {"probability": {"variance": 0.002447, "average": 0.976217, "min": 0.783353}, "location": {"width": 943, "top": 977, "height": 71, "left": 239}, "words": "胆红素≥2倍正常最高上限(ULN);3)活动性或未控制的感染"}, {"probability": {"variance": 0.002913, "average": 0.972477, "min": 0.828194}, "location": {"width": 416, "top": 1060, "height": 53, "left": 237}, "words": "给药方案二(5天给药方案"}, {"probability": {"variance": 0.004265, "average": 0.967531, "min": 0.737918}, "location": {"width": 1069, "top": 1107, "height": 73, "left": 308}, "words": "地西他滨的给药剂量为20mgm2,连续静脉输注1小时,每天一次,连续5"}, {"probability": {"variance": 0.02062, "average": 0.927448, "min": 0.450742}, "location": {"width": 787, "top": 1147, "height": 62, "left": 232}, "words": "天。每4周重复一个周期。患者可预先使用常规止吐药"}, {"probability": {"variance": 0.032993, "average": 0.913837, "min": 0.352497}, "location": {"width": 1055, "top": 1192, "height": 71, "left": 310}, "words": "如果出现骨髓抑制,后续治疗周期应推迟至德学指标恢复"}, {"probability": {"variance": 0.027035, "average": 0.915449, "min": 0.353054}, "location": {"width": 1131, "top": 1225, "height": 87, "left": 239}, "words": "(ANC≥1,0/L,血小板≥50L。如果出现丰血液学毒性应参照方案"}, {"probability": {"variance": 6.3e-05, "average": 0.993898, "min": 0.982636}, "location": {"width": 98, "top": 1281, "height": 35, "left": 234}, "words": "一处理"}, {"probability": {"variance": 0.001723, "average": 0.989116, "min": 0.763824}, "location": {"width": 1060, "top": 1362, "height": 73, "left": 301}, "words": "基于国外临床研究数据提示与3天给药方案相比5天给药方案具有更好的"}, {"probability": {"variance": 0.020459, "average": 0.93846, "min": 0.384747}, "location": {"width": 1138, "top": 1397, "height": 87, "left": 223}, "words": "耐受性。该方案已经在外获得批准。中国人群应用经验有限请治医生报据"}, {"probability": {"variance": 0.030678, "average": 0.908329, "min": 0.354789}, "location": {"width": 534, "top": 1451, "height": 53, "left": 225}, "words": "中国自身状况选择合理给药方案"}, {"probability": {"variance": 0.000389, "average": 0.988176, "min": 0.94475}, "location": {"width": 196, "top": 1538, "height": 42, "left": 223}, "words": "静脉给药操作"}, {"probability": {"variance": 0.008891, "average": 0.964726, "min": 0.556164}, "location": {"width": 1084, "top": 1576, "height": 71, "left": 275}, "words": "地西他滨是细胞毒性药物,操作和配制地西他滨时应当小心应当系用恰当"}, {"probability": {"variance": 0.003469, "average": 0.979514, "min": 0.768403}, "location": {"width": 465, "top": 1626, "height": 49, "left": 219}, "words": "的处理和处置抗肿瘤药物的手段"}, {"probability": {"variance": 0.024397, "average": 0.93147, "min": 0.356328}, "location": {"width": 1075, "top": 1668, "height": 78, "left": 270}, "words": "本品应当在无菌条件下用10mL注射用水复溶;配制成每毫升约含50"}, {"probability": {"variance": 0.019641, "average": 0.924488, "min": 0.401217}, "location": {"width": 1129, "top": 1713, "height": 69, "left": 212}, "words": "地西他滨,pH6.7~~7.3的溶液。复溶后,立即再用0.9%Nal注射液5%葡萄"}, {"probability": {"variance": 0.00455, "average": 0.971937, "min": 0.634673}, "location": {"width": 1142, "top": 1758, "height": 67, "left": 210}, "words": "糖注射液或乳酸林格氏液进一步稀释成终溶度为0.1~1.0mgmL的溶液。建议即"}, {"probability": {"variance": 0.010641, "average": 0.955619, "min": 0.527923}, "location": {"width": 1145, "top": 1800, "height": 69, "left": 210}, "words": "配即用。如复溶后15分钟示能使用,稀驿液必须用2~8℃的冷输液配制,并在"}, {"probability": {"variance": 0.016967, "average": 0.941211, "min": 0.396923}, "location": {"width": 697, "top": 1849, "height": 51, "left": 210}, "words": "2~8(36F~46F)保存,最多不超过7小时"}, {"probability": {"variance": 0.002775, "average": 0.9863, "min": 0.697662}, "location": {"width": 1055, "top": 1890, "height": 67, "left": 268}, "words": "只要溶液和容器允许,非口服给药的药品在给药前应检查可见异物和颜色"}, {"probability": {"variance": 0.001331, "average": 0.987599, "min": 0.842349}, "location": {"width": 568, "top": 1937, "height": 46, "left": 208}, "words": "当出现可见异物或颜色变化,请勿使用"}, {"probability": {"variance": 0.000764, "average": 0.981933, "min": 0.925038}, "location": {"width": 176, "top": 2017, "height": 40, "left": 216}, "words": "【不良反应】"}, {"probability": {"variance": 0.00681, "average": 0.967394, "min": 0.556119}, "location": {"width": 1149, "top": 2057, "height": 76, "left": 201}, "words": "本品安全性数据来自杨森公司产品达珂( Dacogen)国外临床研究和临床使月"}, {"probability": {"variance": 0.027596, "average": 0.854601, "min": 0.549922}, "location": {"width": 87, "top": 2230, "height": 26, "left": 1346}, "words": "垃西-15"}], "language": 3}